Keyphrases
T Cells
100%
Neuroblastoma
100%
Therapeutic Vaccine
100%
Hematopoietic Stem Cell Transplantation
100%
Syngeneic
100%
Mouse Tumor
100%
Adoptive Transfer
50%
Cell-based
33%
Transplant Recipients
33%
Tumor Immunity
33%
Protective Immunity
33%
CD25+
33%
Tumor Vaccination
33%
Grafting from
16%
Transplantation
16%
Costimulatory Molecules
16%
Tumor
16%
Tumor-specific
16%
Spleen
16%
CD4+
16%
CD8+ T Cells
16%
Tumor Challenge
16%
CD4 T Cells
16%
Autoreactive T Cells
16%
Translational Studies
16%
Cancer Vaccine
16%
CD4+CD25+Foxp3+
16%
Splenocytes
16%
T Cell Immunity
16%
Plasmid DNA (pDNA)
16%
Event-free Survival
16%
Vaccine Administration
16%
Transient Transfection
16%
Vector Encoding
16%
Anti-CD25
16%
FoxP3+ Cells
16%
Antitumor T Cells
16%
Mouse Neuroblastoma Cells
16%
Autologous HSCT
16%
DNA Vector
16%
Anti-neuroblastoma
16%
T Cell Reconstitution
16%
Enzyme-linked Immunosorbent Spot Assay
16%
Post-HSCT
16%
Immunology and Microbiology
Mouse
100%
Syngenic
100%
Tumor Vaccine
100%
T Cell
100%
Hematopoietic Stem Cell Transplantation
100%
CD25
50%
T-Helper Cell
25%
Transplant Procedure
25%
Vaccination Policy
25%
Vaccine Efficacy
12%
Splenocyte
12%
Adoptive Immunity
12%
Enzyme-Linked Immunospot Assay
12%
Cell-Based Vaccine
12%
Cytotoxic T-Cell
12%
CD4
12%
Plasmid
12%
Autologous Hematopoietic Stem Cell Transplantation
12%
Transient Transfection
12%
Event Free Survival
12%
Neuroblastoma Cell
12%
DNA Vector
12%
Cancer Vaccine
12%
Medicine and Dentistry
Hematopoietic Stem Cell Transplantation
100%
Tumor Vaccine
100%
Ganglioneuroblastoma
100%
T Cell
100%
Neoplasm
37%
Adoptive Transfer
37%
Transplantation
25%
Cancer Immunization
25%
T-Helper Cell
25%
Transient Transfection
12%
Event Free Survival
12%
Cellular Immunity
12%
Neuroblastoma Cell
12%
Autologous Hematopoietic Stem Cell Transplantation
12%
Enzyme Linked Immunospot Assay
12%
Plasmid DNA
12%
Cancer Vaccine
12%
DNA Vector
12%
Specific Tumor
12%
Cytotoxic T-Cell
12%